Source:http://linkedlifedata.com/resource/pubmed/id/15707400
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2005-2-14
|
pubmed:abstractText |
T-cell depletion facilitates reduced immunosuppression following organ transplantation and has been suggested to be pro-tolerant. However, the characteristics of post-depletional T cells have not been evaluated as they relate to tolerance induction. We therefore studied patients undergoing profound T-cell depletion with alemtuzumab or rabbit anti-thymocyte globulin following renal transplantation, evaluating the phenotype and functional characteristics of their residual cells. Naive T cells and T cells with potential regulatory function (CD4+CD25+) were not prevalent following aggressive depletion. Rather, post-depletion T cells were of a single phenotype (CD3+CD4+CD45RA-CD62L-CCR7-) consistent with depletion-resistant effector memory T cells that expanded in the first month and were uniquely prevalent at the time of rejection. These cells were resistant to steroids, deoxyspergualin or sirolimus in vitro, but were calcineurin-inhibitor sensitive. These data demonstrate that therapeutic depletion begets a limited population of functional memory-like T cells that are easily suppressed with certain immunosuppressants, but cannot be considered uniquely pro-tolerant.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal,
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, Humanized,
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Neoplasm,
http://linkedlifedata.com/resource/pubmed/chemical/Calcineurin,
http://linkedlifedata.com/resource/pubmed/chemical/Immunosuppressive Agents,
http://linkedlifedata.com/resource/pubmed/chemical/alemtuzumab
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
1600-6135
|
pubmed:author |
pubmed-author:BernsteinWendy BWB,
pubmed-author:HaleDouglas ADA,
pubmed-author:HoffmannSteven CSC,
pubmed-author:KirkAllan DAD,
pubmed-author:MannonRoslyn BRB,
pubmed-author:McCoyKelly LKL,
pubmed-author:ParrisJeremyJ,
pubmed-author:PearlJonathan PJP,
pubmed-author:RoedererMarioM,
pubmed-author:SwansonS JohnSJ
|
pubmed:issnType |
Print
|
pubmed:volume |
5
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
465-74
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:15707400-Antibodies, Monoclonal,
pubmed-meshheading:15707400-Antibodies, Monoclonal, Humanized,
pubmed-meshheading:15707400-Antibodies, Neoplasm,
pubmed-meshheading:15707400-CD4-Positive T-Lymphocytes,
pubmed-meshheading:15707400-Calcineurin,
pubmed-meshheading:15707400-Humans,
pubmed-meshheading:15707400-Immunologic Memory,
pubmed-meshheading:15707400-Immunosuppressive Agents,
pubmed-meshheading:15707400-Kidney Transplantation,
pubmed-meshheading:15707400-T-Lymphocyte Subsets
|
pubmed:year |
2005
|
pubmed:articleTitle |
Immunocompetent T-cells with a memory-like phenotype are the dominant cell type following antibody-mediated T-cell depletion.
|
pubmed:affiliation |
Transplantation Branch, National Institute of Diabetes, Digestive and Kidney Diseases, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland, USA.
|
pubmed:publicationType |
Journal Article
|